Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anders Dejgaard

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|October 22, 2003
Update on Novo Nordisk's clinical trial programme on NovoSevenAnders Dejgaard
Ugeskrift for Laeger|January 26, 2008
[Coloured attitudes]Anders Dejgaard
Ugeskrift for Laeger|February 26, 2003
[Health research--industry's point of view]Anders Dejgaard, Børge Diderichsen
Ugeskrift for Laeger|May 22, 2003
[The roles and responsibilities of the pharmaceutical industry]Anders Dejgaard, Mads Krogsgaard Thomsen
Lancet (London, England)|June 15, 2007
Type I and type IV allergy to insulin detemirAnders Dejgaard, Jens Larsen, Christian Ross Pedersen
Scandinavian Journal of Clinical and Laboratory Investigation|November 19, 2008
Targeting postprandial hyperglycaemia in patients with recently diagnosed type 2 diabetes with a fixed, weight-based dose of insulin AspartCharlotte Gredal, Anne Mette Rosenfalck, Anders Dejgaard, et al.
The Journal of Clinical Endocrinology and Metabolism|March 7, 2013
Glucagon-like peptide-1 (GLP-1): effect on kidney hemodynamics and renin-angiotensin-aldosterone system in healthy menJeppe Skov, Anders Dejgaard, Jørgen Frøkiær, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|October 22, 2003
Update on Novo Nordisk's clinical trial programme on NovoSevenAnders Dejgaard
Ugeskrift for Laeger|January 26, 2008
[Coloured attitudes]Anders Dejgaard
Ugeskrift for Laeger|February 26, 2003
[Health research--industry's point of view]Anders Dejgaard, Børge Diderichsen
Ugeskrift for Laeger|May 22, 2003
[The roles and responsibilities of the pharmaceutical industry]Anders Dejgaard, Mads Krogsgaard Thomsen
Lancet (London, England)|June 15, 2007
Type I and type IV allergy to insulin detemirAnders Dejgaard, Jens Larsen, Christian Ross Pedersen
Scandinavian Journal of Clinical and Laboratory Investigation|November 19, 2008
Targeting postprandial hyperglycaemia in patients with recently diagnosed type 2 diabetes with a fixed, weight-based dose of insulin AspartCharlotte Gredal, Anne Mette Rosenfalck, Anders Dejgaard, et al.
The Journal of Clinical Endocrinology and Metabolism|March 7, 2013
Glucagon-like peptide-1 (GLP-1): effect on kidney hemodynamics and renin-angiotensin-aldosterone system in healthy menJeppe Skov, Anders Dejgaard, Jørgen Frøkiær, et al.
Pageof 1